|
Art's-Way Manufacturing Co., Inc. (ARTW): BCG Matrix [Dec-2025 Updated] |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Art's-Way Manufacturing Co., Inc. (ARTW) Bundle
You're looking at Art's-Way Manufacturing Co., Inc. (ARTW) right now, and the picture is definitely split: the Modular Buildings unit is firing on all cylinders, seeing sales jump 47.5% in Q1 2025 and driving $1.971 million in operating income last year, clearly marking it as a Star. Meanwhile, the traditional Agricultural Products business is deep in a cyclical trough, with sales down 20.7% in the first half of fiscal 2025 and logging a $(1.510) million operating loss in FY 2024, placing much of it in the Dog or Question Mark quadrants. Honestly, the company's near-term fate hinges on which segment can sustain momentum while the other recovers; let's map out this portfolio using the four quadrants to see exactly where resources should flow next.
Background of Art's-Way Manufacturing Co., Inc. (ARTW)
Art's-Way Manufacturing Co., Inc. is a company that designs, builds, and distributes equipment for agricultural and research needs. You'll find them headquartered in Armstrong, IA. The company operates in the Machinery (B2B) sector, focusing on manufacturing and AgTech verticals. Art's-Way Manufacturing Co., Inc. is publicly traded on The Nasdaq Stock Market LLC under the symbol ARTW. As of October 1, 2025, the stock price was noted at $2.61, giving the company a market capitalization of about $13.3 million based on 5.11 million shares outstanding. That's a tight ship, honestly.
The operations of Art's-Way Manufacturing Co., Inc. are organized into two primary reportable segments. First, there's the Agricultural Products segment, which fabricates and sells farming products, related equipment, and replacement parts across the United States and globally. Second, the Modular Buildings segment manufactures and installs specialized modular buildings, often used for animal containment or various laboratory applications. The company previously had a Tools segment, but it has since ceased operations there, eliminating those associated losses. The strategic focus is now squarely on these two continuing areas.
Looking at the most recent performance data available, which covers the second quarter and the first nine months of fiscal 2025, the picture is one of operational improvement despite some sales softness. For the second quarter of fiscal 2025, Art's-Way Manufacturing Co., Inc. reported sales of $6.34 million, which was a 5.8% dip compared to the same period in 2024. For the first six months of 2025, total sales came in at $11.48 million, down 7.8% year-over-year. However, the story on profitability is much better; the company posted a net income of $1.48 million for Q2 2025, a significant swing from a net loss of $5,000 the year prior. This turnaround was helped by a $1.62 million Employee Retention Credit refund and a reduction in operating expenses by 15.3% over the first half of the year due to right-sizing staff.
The segments show different trends. The Modular Buildings segment is showing continued strength, with Q2 2025 sales actually up 6.3% year-over-year, driven by strong demand for containment and lab structures. Conversely, the Agricultural Products segment has faced headwinds, seeing sales decline as rising interest rates and lower commodity prices temper demand in the broader farm equipment space. As of August 31, 2025, the trailing twelve-month revenue for Art's-Way Manufacturing Co., Inc. stood at $24.1 million.
Art's-Way Manufacturing Co., Inc. (ARTW) - BCG Matrix: Stars
You're analyzing the portfolio for Art's-Way Manufacturing Co., Inc. (ARTW), and the Modular Buildings segment clearly fits the profile of a Star. This segment is characterized by high market share in a growing market, demanding significant investment to maintain that leadership position.
The recent performance metrics definitely underscore this high-growth, high-share status. For the first quarter of fiscal 2025, the Modular Buildings segment posted sales of $2.19 million, representing a substantial year-over-year increase of 47.5%. This growth is being fueled by specific, high-value product lines within the segment.
Specifically, the specialized research and animal containment modular units are driving this expansion. In fiscal 2024, these units were responsible for a 124% increase in research sales. This indicates that Art's-Way Manufacturing Co., Inc. is capturing significant market share in a sector that is expanding rapidly.
This segment is the primary profit engine for the company right now. For the full fiscal year 2024, the Modular Buildings segment delivered an operating income of $1.971 million. This profitability is supported by a high gross margin, which reached 32.1% in fiscal 2024.
The forward-looking indicators suggest this momentum is set to continue, which is key for a Star to eventually transition into a Cash Cow. You see this sustained strength in the nine-month results ending August 31, 2025, where Modular Buildings sales were up 21.4% compared to the first nine months of fiscal 2024.
Here's a snapshot of the recent segment performance supporting its Star classification:
| Metric | Value | Period/Year | Source of Strength |
| Segment Sales Growth | 47.5% | Q1 2025 vs. Q1 2024 | Strong Market Demand |
| Research Sales Growth | 124% | Fiscal 2024 | Specialized Unit Success |
| Segment Operating Income | $1.971 million | FY 2024 | Primary Profit Driver |
| Segment Gross Margin | 32.1% | FY 2024 | High Profitability Execution |
The strategy here, as a Star, is to invest heavily to keep up with the high growth rate and secure that market leadership. You need to ensure promotion and placement support keeps pace with the demand you're seeing in the non-ag research markets.
The current indicators point toward continued high market growth:
- Strong leads currently in the engineering phase for future contracts.
- Nine-month sales for the segment (ending August 31, 2025) increased 21.4%.
- Q3 2025 sales alone were up 19.4% from Q3 2024.
- The segment is noted for benefiting greatly from strong performance year-to-date in fiscal 2025.
If Art's-Way Manufacturing Co., Inc. sustains this success as the high-growth market eventually matures, this unit is defintely positioned to become a Cash Cow.
Art's-Way Manufacturing Co., Inc. (ARTW) - BCG Matrix: Cash Cows
The Grinder-mixers and related animal feed processing equipment line, housed within the Agricultural Products segment of Art's-Way Manufacturing Co., Inc., represents the classic Cash Cow profile. This unit operates in a mature segment of the agricultural equipment market but maintains a high relative market share, evidenced by its status as a core product line that continues to generate revenue even when the broader row crop market faces headwinds.
Here are the key financial figures for the Agricultural Products segment for the first half of fiscal 2025, which illustrate its cash-generating nature:
| Metric | Period Ending May 31, 2025 (Six Months) | Period Ending May 31, 2024 (Six Months) |
| Sales Amount | $6,973,000 | Decline of 20.7% from prior year |
| Gross Profit Change | Declined 1.0% | N/A |
| Operating Expenses Reduction | 24.2% | N/A |
| Q2 2025 Gross Margin | 27.2% | 29.0% |
Stable demand for this core product line is currently being driven by record-high livestock prices in fiscal 2025, which provides a necessary counter-balance to the overall agricultural downturn caused by weakened row crop prices and high interest rates. Art's-Way Manufacturing Co., Inc.'s long-standing market presence in this livestock equipment niche implies the high relative market share required for a Cash Cow designation, as farmers rely on established, durable equipment.
The focus for Art's-Way Manufacturing Co., Inc. on this segment is clearly on efficiency and milking the existing cash flow, rather than aggressive growth investment, which aligns with Cash Cow strategy. The company has actively worked to sustain margins through operational improvements:
- Operating expenses for the segment were reduced by 24.2% for the six months ending May 31, 2025, compared to the prior year period.
- Streamlined staffing efforts in fiscal 2024 continue to reduce overhead costs.
- The company is focused on improving liquidity and cash flow positions.
- A new 8215 Grinder Mixer model is currently priced around $97,200 on the resale market.
The 8215 model itself showcases the high-value proposition, boasting a 215 bushel capacity for more efficient feed processing.
Art's-Way Manufacturing Co., Inc. (ARTW) - BCG Matrix: Dogs
You're looking at the Art's-Way Manufacturing Co., Inc. Agricultural Products segment, and honestly, the numbers paint a clear picture of a business unit that fits squarely into the Dogs quadrant. This segment operates in what is clearly a down cycle for the broader farm equipment industry, characterized by low growth and, for Art's-Way Manufacturing Co., Inc., a low relative market share in certain product lines.
The recent financial performance confirms this positioning. For the first six months of fiscal 2025, the segment's sales saw a significant contraction, declining by 20.7% compared to the same period in the prior year. This trend of contraction was also evident in the first quarter of fiscal 2025, where sales dropped 30.4% year-over-year to $2.95 million. While the second quarter showed some moderation in the decline, sales were still down 11.6% to $4.025 million. The nine months ended August 31, 2025, showed a cumulative sales decline of 15.5% to $9.956 million.
This segment houses lines like sugar beet harvesting equipment and dirt work equipment, which operate in markets described as low-growth and highly competitive. Expensive turn-around plans are usually not the answer here; the focus shifts to minimizing cash consumption. To be fair, management has been working on cost control, as evidenced by the 24.2% reduction in operating expenses for the six months ending May 31, 2025, compared to the same period in fiscal 2024.
The profitability struggle in the Agricultural Products segment is stark when you look at the fiscal 2024 results. The segment posted an operating loss of $(1.510) million for the full fiscal year 2024, a sharp reversal from the operating income of $664,000 in fiscal 2023. This loss indicates that, even before the deeper sales slump of early 2025, the segment was consuming cash rather than generating it.
Here's a quick look at the segment's recent financial snapshot:
| Metric | Period | Value |
|---|---|---|
| Net Sales | Fiscal 2024 | $14.66 million |
| Operating Income (Loss) | Fiscal 2024 | $(1.510) million |
| Gross Profit Margin | Fiscal 2024 | 28.3% |
| Sales Decline | First Six Months of Fiscal 2025 | 20.7% |
| Sales | First Six Months of Fiscal 2025 | $6.973 million |
| Gross Profit Change | First Six Months of Fiscal 2025 | Declined 1.0% |
The characteristics pointing toward a Dog classification for these specific product lines include:
- Market facing a significant down cycle due to high interest rates and low commodity prices.
- Fiscal 2024 operating loss of $(1.510) million.
- Sales decline of 20.7% for the first six months of fiscal 2025.
- Specific lines like sugar beet harvesting equipment and dirt work equipment are non-core.
- Management is focused on cost reductions to weather the bottom of the cycle.
The company is actively trying to manage this unit, as seen by the focus on cost reductions implemented in fiscal 2024, which were expected to help in fiscal 2025. Still, the segment frequently breaks even or consumes cash, making divestiture a prime consideration for units that don't offer growth potential. Finance: draft the projected cash flow impact of a 25% reduction in Ag Products operating expenses for the next two quarters by Friday.
Art's-Way Manufacturing Co., Inc. (ARTW) - BCG Matrix: Question Marks
You're looking at the Agricultural Products segment of Art's-Way Manufacturing Co., Inc. as the primary Question Mark category. These are units operating in a market that is expected to grow-the cyclical agricultural sector-but where the company currently holds a low relative market share, meaning they consume cash while waiting for the cycle to turn. Art's-Way Manufacturing Co., Inc. is actively positioning this segment for a turnaround. This involves new program releases and targeted inventory builds for the Agricultural Products segment, aimed at a cyclical recovery. For the six months ending May 31, 2025, the company was positioning for future growth through these targeted inventory builds and program releases to improve liquidity.
The segment has faced significant headwinds, which is characteristic of a Question Mark needing a decision on investment or divestiture. Specifically, the company saw its Agricultural Products segment sales decline by 34.7% in Fiscal Year 2024. This decline was attributed to low crop prices and elevated dealer inventories. Products like forage equipment, which includes forage boxes and bale processors, are part of this unit subject to the broader market recovery. For the first six months of fiscal 2025, Agricultural Products segment sales were $6,973,000, representing a 20.7% decline compared to the first six months of fiscal 2024.
The near-term financial stability, which underpins the ability to support this segment, relies heavily on non-recurring items. The overall financial turnaround for the first half of fiscal 2025, which resulted in a six-month net income of $1,426,000, was significantly bolstered by a one-time $1.62 million Employee Retention Credit refund. Without this non-operational boost, sustained profitability remains uncertain until the agricultural market recovery materializes, which management anticipates over the next 12-18 months.
The strategy here is clearly to invest to gain share or risk the unit becoming a Dog. This means any new product development in the Ag segment that requires significant investment but currently holds low market share must be carefully evaluated against the potential for the cyclical upswing. The company is keeping a close eye on the impact of tariffs on both costs and demand profile amid this investment need.
Here is a look at the recent performance metrics for the segment that defines this Question Mark:
| Metric | Fiscal Year 2024 (Full Year) | First Six Months of Fiscal 2025 (Ending May 31, 2025) |
| Agricultural Products Segment Sales | $14.663M | $6,973,000 |
| Year-over-Year Sales Change (vs. Prior Period) | -34.7% (FY 2024 vs FY 2023) | -20.7% (H1 FY2025 vs H1 FY2024) |
| Segment Gross Margin | 28.3% | Declined 1.0% (vs. H1 FY2024) |
| Segment Backlog | ~$3.486M (as of 8/31/2024) | Not explicitly stated for this period |
The management team is focused on specific actions to try and shift this unit out of the Question Mark quadrant:
- Streamlined staffing efforts in fiscal 2024 to reduce overhead.
- Reducing operating expenses by 15.3% for the six months ending May 31, 2025.
- Building stock inventory in Q3 of fiscal 2025 to react to retail opportunities.
- Releasing product-specific programs to turn inventory and unlock cash.
The company's stock price as of October 1, 2025, was $2.61, with a market capitalization of $13.3M. Finance: draft scenario analysis for Ag segment sales recovery of 15% and 30% in H2 FY2025 by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.